Showing results (151-160 of 177) with videos related to
Sort By:
Pageof 18
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 25, 2024
[Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia]H P Dai, H J Shen, Z Li, et al.Biochemical Pharmacology|December 15, 1982
Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cellsS F Chen, J D Stoeckler, H S Choi, et al.Contraception|March 1, 1995
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effectsG W Sang, Q X Shao, R S Ge, et al.Journal of Gastroenterology and Hepatology|May 1, 1994
A study of primary- and re-infection with hepatitis C virus in blood transfusion recipientsZ D Meng, D G Xu, D G Sun, et al.Cancer Research|April 15, 1994
(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitroM R Kirshenbaum, S F Chen, C H Behrens, et al.Contraception|March 1, 1995
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patternsG W Sang, Q X Shao, R S Ge, et al.Anti-Cancer Drugs|August 1, 1993
XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 4, 2024
[Prevalence and progression of subclinical atherosclerosis in populations with different cardiovascular disease risks in China]S Y Zhou, F C Liu, S F Chen, et al.European Journal of Neurology|June 28, 2007
Time course of cerebral hemodynamics in cryptococcal meningitis in HIV-negative adultsW-N Chang, C-H Lu, H-W Chang, et al.Zhonghua Xin Xue Guan Bing Za Zhi|November 19, 2020
[Cardiovascular disease risk in diabetes patients aged 40 years old and above in China]J X Li, Y Li, F C Liu, et al.Pageof 18